The Impact of Cultural Factors on Post-Acquisition Integration: Domestic and Foreign Acquisitions of Finnish Companies in 1993-2004

Acquisitions are a central component of corporate strategy. They contribute to competitive advantage by offering possibilities for both cost reductions and for revenue enhancements. However, many acquisition benefits cannot be realized without a successful integration of the acquiring and the acquired firms. Previous research shows that national and organizational culture can play a major role in determining the integration outcomes. Therefore, the overall aim of the thesis is to map out and illustrate the impact mechanisms of cultural factors in post-acquisition integration in order to explain the cultural aspects of acquisitions. This study has three main contributions. First, the study shows that international and domestic acquisitions differ concerning both strategic and cultural fit. Second, the findings highlight the importance of acculturation and cultural integration in determining post-acquisition outcomes. Finally, the study uncovers several impact mechanisms that shed light to the contradictory results related to cultural differences in previous research.

A Split-and-Merge Dictionary Learning Algorithm for Sparse Representation: Application to Image Denoising

In big data image/video analytics, we encounter the problem of learning an over-complete dictionary for sparse representation from a large training dataset, which cannot be processed at once because of storage and computational constraints. To tackle the problem of dictionary learning in such scenarios, we propose an algorithm that exploits the inherent clustered structure of the training data and make use of a divide-and-conquer approach. The fundamental idea behind the algorithm is to partition the training dataset into smaller clusters, and learn local dictionaries for each cluster. Subsequently, the local dictionaries are merged to form a global dictionary. Merging is done by solving another dictionary learning problem on the atoms of the locally trained dictionaries. This algorithm is referred to as the split-and-merge algorithm. We show that the proposed algorithm is efficient in its usage of memory and computational complexity, and performs on par with the standard learning strategy, which operates on the entire data at a time. As an application, we consider the problem of image denoising. We present a comparative analysis of our algorithm with the standard learning techniques that use the entire database at a time, in terms of training and denoising performance. We observe that the split-and-merge algorithm results in a remarkable reduction of training time, without significantly affecting the denoising performance.

Region Segmentation via Deformable Model-Guided Split and Merge

An improved method for deformable shape-based image segmentation is described. Image regions are merged together and/or split apart, based on their agreement with an a priori distribution on the global deformation parameters for a shape template. The quality of a candidate region merging is evaluated by a cost measure that includes: homogeneity of image properties within the combined region, degree of overlap with a deformed shape model, and a deformation likelihood term. Perceptually-motivated criteria are used to determine where/how to split regions, based on the local shape properties of the region group's bounding contour. A globally consistent interpretation is determined in part by the minimum description length principle. Experiments show that the model-based splitting strategy yields a significant improvement in segmention over a method that uses merging alone.

Mergers, Acquisitions, and Alliances

© 2012 by Oxford University Press. All rights reserved.This article considers the determinants and effects of M&As in the pharmaceutical industry, with a particular focus on innovation and R&D productivity. As is the case in other industries, mergers in the pharmaceutical field are driven by a variety of company motives and conditions. These include defensive responses to industry shocks as well as more proactive rationales, such as economies of scale and scope, access to new technologies, and expansion to new markets. It is important to take account of firms' characteristics and motivations in evaluating merger performance, rather than using a broad aggregate brushstroke. Research to date on pharmaceuticals suggests considerable variation in both motivation and outcomes. From an antitrust policy standpoint, the larger horizontal mergers in pharmaceuticals have run into few challenges from regulatory authorities in the United States and the European Union, given the option to spin off competing therapeutic products to other drug firms.